C533 Pill - blue capsule/oblong, 17mm
Pill with imprint C533 is Blue, Capsule/Oblong and has been identified as Tenofovir Disoproxil Fumarate 300 mg. It is supplied by Cipla USA Inc.
Tenofovir is used in the treatment of Hepatitis B; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tenofovir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C533
Tenofovir Disoproxil Fumarate
- Imprint
- C533
- Strength
- 300 mg
- Color
- Blue
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0533
- Inactive Ingredients
-
lactose monohydrate,
croscarmellose sodium,
corn starch,
polysorbate 80,
microcrystalline cellulose,
magnesium stearate,
titanium dioxide,
triacetin,
FD&C Blue No. 2,
hypromellose 2910 (15 mPa.s)
Note: Inactive ingredients may vary.
More about tenofovir
- Check interactions
- Compare alternatives
- Reviews (26)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
- Tenofovir drug information
- Tenofovir (Advanced Reading)
- Tenofovir Disoproxil Fumarate Tablets
- Tenofovir Disoproxil Fumarate Oral Powder
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
